Adidas said on Friday its first-quarter numbers came in better than expected, although sales dipped 1% from a year-ago period, as investors hope for the German sportswear giant to turn its fortunes around. Adidas (OTC:ADDYY), which last year ended a lucrative partnership with Ye, the rapper formerly known as Kanye West, gave no update on
READ MORE
The Fate of Abundance Advancements Investigated: third Yearly Center East Wealth Tech Gathering and Grants 2023 Abundance advancements allude to the utilization of imaginative innovations, for example, computerized reasoning and large information to give an option in contrast to customary abundance the executives firms. This is utilized fully intent on making abundance the board and
READ MORE
Most Asian stock markets kept to a tight range on Thursday as investors mulled over rising interest rates and a worsening economic outlook, although strong holiday spending figures from China supported local shares. China’s Shanghai Composite index rose 0.6%, while losses in the Shanghai Shenzhen CSI 300 index were limited as local markets reopened after
READ MORE
Inc has resumed taking orders for its Model 3 long-range version in the United States, the company’s website showed late on Tuesday, after a temporary halt last year due to delivery backlogs. The long-range version of the entry-level Model 3 is priced at $47,240 currently, about 18.5% less than the $57,990 it was priced at
READ MORE
Sony (NYSE:SONY) Group Corp’s shares fell as much as 4.8% on Monday after the Japanese electronics and entertainment conglomerate’s annual profit outlook fell short of market expectations. The company on Friday posted a record operating profit for the year ended March 2023, driven by a robust performance at its music and microchip units. For the
READ MORE
Pfizer Inc (NYSE:PFE) has pledged to deliver critical new medicines more quickly in low-income nations, but its first such vaccine effort faces hurdles likely to delay distribution in poorer countries by several years, global health officials told Reuters. Pfizer made a commitment on more equitable access last year, following criticism that it prioritized wealthy nations
READ MORE
Maecenas mauris elementum, est morbi interdum cursus at elite imperdiet libero. Proin odios dapibus integer an nulla augue pharetra cursus.
33 Farlane Street
25-100 Keilor East,
Australia
Phone: 1-800-64-38
Fax: 1-800-64-39
